| Basics |
Medpace Holdings, Inc.
Medpace Holdings Inc is a clinical contract research organisation. It is engaged in providing scientifically-driven clinical research-based drug and medical device development services to the biotechnology, pharmaceutical and medical device industries.
|
| IPO Date: |
August 11, 2016 |
| Sector: |
Healthcare |
| Industry: |
Medical Diagnostics and Research |
| Market Cap: |
$13.68B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$2.56 | 1.64%
|
| Avg Daily Range (30 D): |
$5.62 | 1.26%
|
| Avg Daily Range (90 D): |
$5.59 | 1.55%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.28M |
| Avg Daily Volume (30 D): |
.31M |
| Avg Daily Volume (90 D): |
.36M |
| Trade Size |
| Avg Trade Size (Sh.): |
46 |
| Avg Trade Size (Sh.) (30 D): |
25 |
| Avg Trade Size (Sh.) (90 D): |
28 |
| Institutional Trades |
| Total Inst.Trades: |
2,977 |
| Avg Inst. Trade: |
$5.78M |
| Avg Inst. Trade (30 D): |
$20.17M |
| Avg Inst. Trade (90 D): |
$16.3M |
| Avg Inst. Trade Volume: |
.04M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$6.97M |
| Avg Closing Trade (30 D): |
$19.94M |
| Avg Closing Trade (90 D): |
$16.81M |
| Avg Closing Volume: |
40.86K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$13.84
|
$3.16
|
$3.77
|
|
Diluted EPS
|
$13.47
|
$3.1
|
$3.67
|
|
Revenue
|
$ 2.23B
|
$ 603.31M
|
$ 558.57M
|
|
Gross Profit
|
$ 705.69M
|
$ 180.01M
|
$ 178.35M
|
|
Net Income / Loss
|
$ 418.3M
|
$ 90.26M
|
$ 114.6M
|
|
Operating Income / Loss
|
$ 477.51M
|
$ 126.34M
|
$ 113.52M
|
|
Cost of Revenue
|
$ 1.53B
|
$ 423.3M
|
$ 380.22M
|
|
Net Cash Flow
|
$ -464.56M
|
$ -395.11M
|
$ -228M
|
|
PE Ratio
|
36.19
|
|
|
|
|
|
